PHK
SIOX

Point72 Hong Kong’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

Point72 Hong Kong’s Portfolio SIOX Stock Details SIOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-434
Closed -$5K – 1270
2018
Q1 		$5K Buy
+434
New +$6.97K ﹤0.01% 740
2017
Q4 		– Sell
-154
Closed -$8K – 1153
2017
Q3 		$8K Buy
+154
New +$26K 0.01% 522
2017
Q2 		– Sell
-456
Closed -$54K – 1080
2017
Q1 		$54K Buy
456
+137
+43% +$14.4K 0.07% 219
2016
Q4 		$32K Buy
319
+119
+60% +$12.5K 0.03% 464
2016
Q3 		$22K Buy
+200
New +$24K 0.01% 576

Other funds holding SIOX

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
MWNA
Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Point72 Hong Kong's SIOX Position: Q2 2018 in Review

Point72 Hong Kong sold out of Sio Gene Therapies Inc. Common Stock (SIOX) in Q2 2018, closing a stake of 434 shares — an estimated $5K sold.

Point72 Hong Kong first reported a position in SIOX in Q3 2016 and held it in 5 quarters. The position peaked at $54K in Q1 2017. 71 funds tracked by Wall St. Rank hold SIOX as of Q2 2018.

  • Point72 Hong Kong reported no remaining Sio Gene Therapies Inc. Common Stock position as of Q2 2018 after selling out during the quarter.
  • Point72 Hong Kong sold 434 Sio Gene Therapies Inc. Common Stock shares in Q2 2018, an estimated $5K.
  • Point72 Hong Kong first reported a position in Sio Gene Therapies Inc. Common Stock in Q3 2016 and held it in 5 quarters.
  • Point72 Hong Kong's Sio Gene Therapies Inc. Common Stock position peaked at $54K in Q1 2017.
  • 71 funds tracked by Wall St. Rank held Sio Gene Therapies Inc. Common Stock as of Q2 2018.

Based on Point72 Hong Kong's 13F filing for Q2 2018, filed 14 Aug 2018.